Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Life Fitness Delivers on the Future of Fitness, Debuting State-of-the-Art Cardio Line with Next-Gen Biomechanics, Symbio™, at IHRSA 2024 2024-03-06 00:00
DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador 2024-03-05 22:00
Zymo Research Pioneers a Breakthrough in Large-scale Animal-free RNase A Production 2024-03-05 22:00
Angel Yeast Hosts Webinar with PPTI to Promote Sustainable Development of Proteins 2024-03-05 21:00
IRBM Expands Global Reach in Drug Discovery with New Boston Office 2024-03-05 20:24
One Million Global Healthcare Seekers Embrace MedicalTourism.com: Medical Tourism Magazine Leads the Way 2024-03-05 16:00
Cetaphil® Strengthens Ties with the Malaysian Community through Collaborative Partnership with Mira Filzah as the New Face of the Brand in 2024 2024-03-05 14:58
Innovent and AnHeart Therapeutics Announce the NMPA of China Has Accepted Second NDA for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer 2024-03-05 13:35
First Patient Treated in Phase 2 GvHD Trial 2024-03-05 10:08
Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform 2024-03-05 07:01
Cyient Partners with MassMedic to Accelerate MedTech Innovation 2024-03-04 22:00
Optimum Nutrition Launches New Global Marketing Campaign "Unlock More You" 2024-03-04 22:00
Henlius Forecasts Profit in 2023: Achieving first full year of profitability, and ushering in a new phase of high-quality development 2024-03-04 21:19
Milliken & Company Recognized Among the 2024 World's Most Ethical Companies® 2024-03-04 21:00
Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management 2024-03-04 20:00
Hybribio Calls for Raising International HPV Awareness 2024-03-04 18:47
Results from the Clinical Trial of Qilu Pharmaceutical's Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting 2024-03-04 16:53
Caliway Announced Orphan Drug Designation Granted to CBL-514 for the Treatment of Dercum's Disease 2024-03-04 16:22
THAILAND EXPECTS 25% GROWTH IN FITNESS AND MASS PARTICIPATION SPORTS FOR 2024 2024-03-04 09:00
Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children's Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2 2024-03-02 10:26
1 75 76 77 78 79 810